跳至主要内容
临床试验/JPRN-UMIN000031633
JPRN-UMIN000031633招募中未知

A randomized controlled trial comparing PCAB and PPI therapy for Los Angeles classification Grade C/D reflux esophagitis patient - RCT comparing PCAB and PPI for reflux esophagitis

Yokohama City University (Basic research expenditures)0 个研究点目标入组 160 人开始时间: 2018年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)A patient with history of gastrectomy which may cause regurgitation of bile acid or pancreatic juice. (2)A patient who use PPI or H2RA already. (3)A patient with pregnancy. (4)A patient with lactation. (5)Past history of allergy for the drug used in this study. (6)Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. (7)A patient who is disqualified for the study by physicians.

研究者

发起方
Yokohama City University (Basic research expenditures)

相似试验

A randomized controlled trial comparing PCAB and PPI... | 临床试验